PROCEPT BioRobotics Corporation logo PRCT - PROCEPT BioRobotics Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 5
SELL 1
STRONG
SELL
0
| PRICE TARGET: $28.83 DETAILS
HIGH: $35.00
LOW: $20.00
MEDIAN: $29.50
CONSENSUS: $28.83
UPSIDE: 59.46%

About PROCEPT BioRobotics Corporation (https://www.procept-biorobotics.com)

PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.

Key Executives

NAME TITLE DOB SALARY
Larry L. Wood President, Chief Executive Officer & Director 1966 $2,340,003 USD
Kevin Waters Executive Vice President & Chief Financial Officer 1977 $765,898 USD
Alaleh Nouri EVice President, Chief Legal Officer & Corporate Secretary 1979 $699,426 USD
Barry Templin Executive Vice President & Chief Technology Officer
Bijesh Chandran Executive Vice President of Regulatory Affairs & Quality Assurance
Christofer Christoforou Executive Vice President of Operations 1970
Matthew James Bacso Vice President of Investor Relations
Pooja Sharma Rao Executive VP and Chief Strategy & Marketing Officer
Stacey L. Porter Executive VP & Chief People Officer 1975
Stephen J. McGill Senior VP & GM of International 1962

Company Peers

Peer analysis pending, check back in 1-2 minutes.